author-photo

Jaffer A. Ajani

University of Texas MD Anderson Cancer Center

1132

Papers

51305

Citations

Citation Trend

Filter By

Papers (790) Sort By

Journal Conference Others

LBA7 Nivolumab (NIVO) plus chemotherapy (Chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.

2021 Gut
Show All
- Source
- Cite
- Save
Citations (2)
Determinants of Survival for Patients with Neoadjuvant-Treated Node-Negative Gastric Cancer.

2021 Annals of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
ARID1A mutation may define an immunologically active subgroup in patients with microsatellite-stable colorectal cancer.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (7)
Benchmarks for nodal yield and ratio for node-positive gastric cancer.

2021 Surgery
Show All
- Source
- Cite
- Save
Citations (0)
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (0)
Correction to: LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma.

2021 Molecular Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Localized diffuse-type gastric adenocarcinoma: Influence of baseline positron emission tomography on survival and therapy response.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Chemoradiotherapy followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-Analysis

2021 Annals of Surgery
Show All
- Source
- Cite
- Save
Citations (0)
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT2): Challenges and Opportunities in Conducting an MD Anderson Randomized Study in Precision Oncology.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)